C9 Suppression of TNF alpha and Vascular Endothelial Growth Factor in Therapy

Item relates to patent C9 "Suppression of TNF alpha and Vascular Endothelial Growth Factor in Therapy," invented by Marc Feldmann, Ravinder Maini and Ewa Paleolog under applicant Kennedy Institute of Rheumatology.

Alternative title for the patent is "Use of Tumor Necrosis Factor Alpha and Vascular Endothelial Growth Factor for the Manufacture of a Therapeutic Composition."

The item contains papers relating to the filing and prosecution progress for international PCT, European, Japanese and U.S. applications.

See related material for C9 Espacenet listing (includes patent abstract and digital copies of application).

1997-2008

1 file (in 5 parts)

This item requires facilitated access. Email library@wellcomecollection.org to request an appointment.